Lymphoma Trial, Recruiting NCT07167381 Sponsor: First Ascent Biomedical Inc. Condition: Lymphoma
Back to Lymphoma

Lymphoma Trial, Recruiting

NCT07167381
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have cancer that has come back or stopped responding to treatment, and you are 18 years old or younger (if you are between 7 and 17 years old, you would need to sign an agreement form), OR you are 18 years of age or older with cancer that has come back or stopped responding to treatment.
  • You have already received at least one standard cancer treatment before.
  • You are able to share information about your previous cancer treatments and how your body responded to them.
  • You are well enough to receive cancer treatment — for adults, this means your doctor has rated your general health and ability to carry out daily activities as good enough (confirm with trial site).
  • You are scheduled to have, or have recently had, a tumor sample taken through a biopsy, surgical removal, or resection.
  • You are willing to have a blood draw or a cheek swab taken, so that your normal DNA can be compared to the DNA found in your tumor.

Who may not be able to join:

  • You do not have tumor tissue available, or the tumor sample that was collected is too small to be used for the required laboratory tests (less than a specific minimum amount, or samples that do not contain cancer cells as confirmed by a lab review).
  • You are not well enough to receive any cancer treatment.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
First Ascent Biomedical Inc.
Registry
ClinicalTrials.gov
Start date
1 November 2025
Est. completion
1 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Return of treatment recommendations from xDRIVE functional precision medicine platform within a clinically-actionable timeframe

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov